Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection

References

1. Bontrop R. E., Otting N., Niphuis H., Teeuwsen V., Heeney J. L. 1996; The role of histocompatibility complex polymorphism on SIV infection in rhesus macaques. Immunology Letters 51:35–38
   [Google Scholar]
2. Borrow P., Lewicki H., Hahn B. H., Shaw G. M., Oldstone M. B. 1994; Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viraemia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68:6103–6110
   [Google Scholar]
3. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B. A., Shaw G. M. 1997; Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTL) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3:205–211
   [Google Scholar]
4. Bourgault I., Chirat F., Tartar A., Levy J. P., Guillet J. G., Venet A. 1994; Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of Gag- or Nef-specific cytotoxic T lymphocytes by lipopeptides. Journal of Immunology 152:2530–2537
   [Google Scholar]
5. Chakrabarti L., Cumont M. C., Montagnier L., Hurtrel B. 1994; Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. Journal of Virology 68:6634–6642
   [Google Scholar]
6. Chen Z. W., Shen L., Miller M. D., Ghim S. H., Hughes A. L., Letvin N. L. 1992; Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus Gag. Journal of Immunology 149:4060–4066
   [Google Scholar]
7. Chen Z. W., Shen L., Regan J. D., Kou Z., Ghim S. H., Letvin N. L. 1996; The T cell receptor gene usage by simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in rhesus macaques. Journal of Immunology 156:1469–1475
   [Google Scholar]
8. Chen Z., Zhou P., Ho D.D. others 1997; Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. Journal of Virology 71:2705–2714
   [Google Scholar]
9. Cheynier R., Henrichwark S., Hadida F., Pelletier E., Oksenhendler E., Autran B., Wain-Hobson S. 1994; HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373–387
   [Google Scholar]
10. Coudel-Courteille A., LeGrand R., Tulliez M., Guillet J. G., Venet A. 1997; Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection. Journal of Virology 71:1052–1057
    [Google Scholar]
11. Couillin I., Culmann-Penciolelli B., Gomard E., Levy J.-P., Guillet J. G., Saragosti S. 1994; Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-1 Nef protein. Journal of Experimental Medicine 180:1129–1134
    [Google Scholar]
12. Cranage M. P., Whatmore A. M., Sharpe S. A., Cook N., Polyanskaya N., Leech S., Smith J. D., Rud E. W., Dennis M. J., Hall G. A. 1997; Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 229:143–154
    [Google Scholar]
13. Eisenlohr L. C., Yewdell J. W., Bennink J. R. 1992; Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. Journal of Experimental Medicine 175:481–487
    [Google Scholar]
14. Embretson J., Zupanic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. 1993; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362
    [Google Scholar]
15. Ferbas J., Kaplan A. H., Hausner M. A., Hultin L. E., Matud J. L., Liu Z., Panicali D. L., Nerng-Ho H., Detels R., Giorgi J. V. 1995; Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8⁺ lymphocyte activity. Journal of Infectious Diseases 172:329–339
    [Google Scholar]
16. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J., McMichael A., Gotch F. 1995; Early suppression of SIV replication by CD8⁺ Nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1:1167–1173
    [Google Scholar]
17. Gardner M. B. 1996; The history of simian AIDS. Journal of Medical Primatology 25:148–157
    [Google Scholar]
18. Geretti A. M., Dings M. E. M., van Els C.A.C.M., van Baalen C. A., Wijnholds F. J., Borleffs J. C. C., Osterhaus A. D. M. E. 1996; HIV- 1 and EBV specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1 infected persons. Journal of Infectious Diseases 174:34–45
    [Google Scholar]
19. Geretti A. M., Hulskotte E. G. J., Dings M. E. M., van Baalen C. A., van Amerongen G., Osterhaus A. D. M. E. 1997a; Simian immunodeficiency virus (SIV)-specific CD8 + cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H(J5): quantitative analysis by in vitro antigenic stimulation. Vaccine 15:1269–1275
    [Google Scholar]
20. Geretti A. M., Hulskotte E. G. J., Dings M. E. M., van Baalen C. A., van Amerongen G., Osterhaus A.D.M.E. 1997b; CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV)mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26. Journal of General Virology 78:821–824
    [Google Scholar]
21. Goulder P. J. R., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M. A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A. J., Rowland-Jones S. 1997; Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3:212–217
    [Google Scholar]
22. Heeney J. L., Van Els C., De Varies P., Ten Haaft P., Otting N., Koornstra W., Boes J., Dubbes R., Niphuis H., Dings M., Cranage M., Norley S., Jonker M., Bontrop R. E., Osterhaus A. 1994; Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. Journal of Experimental Medicine 180:769–774
    [Google Scholar]
23. Hulskotte E. G. J., Geretti A. M., Siebelink K. H., van Amerongen G., Cranage M. P., Rud E. W., Norley S. G., de Vries P., Osterhaus A. D. M. E. 1995; Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac 32H (J5). Journal of Virology 69:6289–6296
    [Google Scholar]
24. Kent S. J., Hu S. L., Corey L., Morton W. R., Greenberg P. D. 1996; Detection of simian immunodeficiency virus (SIV)-specific CD8 + T cells in macaques protected from SIV challenge by prior subunit vaccination. Journal of Virology 70:4941–4947
    [Google Scholar]
25. Klavinskis L. S., Bermeier L. A., Gao L., Mitchell E., Ward R. G., Layton G., Brookes R., Meyers N. J., Lehner T. 1997; Mucosal or targeted lymph node immunisation of macaques with a particulate SIV p27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. Journal of Immunology 157:2521–2527
    [Google Scholar]
26. Klein M. R., van Baalen C. A., Holwerda A. M., Kerkhof Garde S. R., Bende R. J., Keet I. M. P., Eeftinck-Schattenkerk J. M., Osterhaus A. D. M. E., Miedema F. 1995; Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: different for rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181:1365–1372
    [Google Scholar]
27. Klenerman P., Phillips R., McMichael A. 1996; Cytotoxic T-cell antagonism in HIV-1. Seminars in Virology 7:31–39
    [Google Scholar]
28. Koenig S., Conley A. J., Brewah Y. A., Jones G. M., Leath S., Boots L. J., Davey V., Pantaleo G., Demarest J. F., Carter C., Wannebo C., Yannelli J. R., Rosenberg S. A., Lane H. C. 1995; Transfer ofHIV- 1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Medicine 1:330–336
    [Google Scholar]
29. Koup R. A. 1994; Virus escape from CTL recognition. Journal of Experimental Medicine 180:779–782
    [Google Scholar]
30. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. 1994; Temporal association of cellular immune response with the initial control of viraemia in primary HIV-1 syndrome. Journal of Virology 68:4650–4655
    [Google Scholar]
31. Letvin N. L., Reimann K. A., Yasutomi Y., Ringler D. J., Yamamoto Y. 1994; The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey. Current Topics in Microbiology and Immunology 188:175–184
    [Google Scholar]
32. Lohman B. L., McChesney M. B., Miller C. J., McGowan E., Joye S. M., Van Rompay K. K., Reay E., Antipa L., Pedersen N. C., Marthas M. L. 1994; A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. Journal of Virology 68:7021–7029
    [Google Scholar]
33. Lohman B. L., Miller C. J., McChesney M. B. 1995; Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. Journal of Immunology 155:5855–5860
    [Google Scholar]
34. Lu S., Arthos J., Montefiori D. C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J. C., Wissink J., Mullins J. I., Haynes J. R., Letvin N. L., Wyand M., Robinson H. L. 1996; Simian immunodeficiency virus DNA vaccine trial in macaques. Journal of Virology 70:3978–3991
    [Google Scholar]
35. Miller C. J., McChesney M. B., Lu X., Dailey P. J., Chutkowski C., Lu D., Brosio P., Roberts B., Lu Y. 1997; Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. Journal of Virology 71:1911–1921
    [Google Scholar]
36. Moskophidis D., Zinkernagel R. M. 1995; Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. Journal of Virology 69:2187–2193
    [Google Scholar]
37. Newman M. J., Munroe K. J., Anderson C. A., Murphy C. I., Panicali D. L., Seals J. R., Wu J.-Y., Wyand M. S., Kensil C. R. 1994; Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant. AIDS Research and Human Retroviruses 10:853–861
    [Google Scholar]
38. Osterhaus A. D. M. E., De Vries P., Heeney J. 1992; AIDS vaccine development. Nature 355:684–685
    [Google Scholar]
39. Rothbard J., Pemberton R., Bodmer H., Askonas B. A., Taylor W. R. 1989; Identification of residues necessary for clonal specific recognition of a cytotoxic T cell determinant. EMBO Journal 8:2321–2328
    [Google Scholar]
40. Rowland-Jones S., McMichael A. 1995; Immune responses in HIV- exposed seronegatives; have they repelled the virus?. Current Opinion in Immunology 7:448–455
    [Google Scholar]
41. Ruprecht R. M., Baba T. W., Li A., Ayehunie S., Hu Y., Liska V., Rasmussen R., Sharma P. L. 1996; Live attenuated HIV as a vaccine for AIDS: pros and cons. Seminars in Virology 7:147–155
    [Google Scholar]
42. Seshamma T., Bagasra O., Trono D., Baltimore D., Pomerantz R. J. 1992; Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 89:10663–10667
    [Google Scholar]
43. Shen L., Chen Z. W., Letvin N. L. 1994; The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants. Journal of Immunology 153:5849–5854
    [Google Scholar]
44. Tsomides T., Aldovini A., Johnoson R. P., Walker B. D., Young R. A., Eisen H. N. 1994; Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. Journal of Experimental Medicine 180:1283–1293
    [Google Scholar]
45. Van Baalen C. A., Klein M. R., Geretti A. M., Keet I. M. P., Miedema F., van Els C. A. C. M., Osterhaus A. D. M. E. 1993; Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7:781–786
    [Google Scholar]
46. Van Baalen C. A., Pontesilli O., Huisman R. C., Geretti A. M., Klein M. R., De Wolf F., Miedema F., Gruters R. A., Osterhaus A. D. M. E. 1997; HIV-1 Rev and Tat specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. Journal of General Virology 78:1913–1918
    [Google Scholar]
47. Venet A., Bourgault I., Aubertin A. M., Kieny M. P., Levy J. P. 1992; Cytotoxic T-lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. Journal of Immunology 148:2899–2908
    [Google Scholar]
48. Von Boehmer H. 1993; Immunology. Tolerance by exhaustion. Nature 362:696
    [Google Scholar]
49. Von Herrath M., Oldstone M. B., Fox H. S. 1995; Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. Journal of Immunology 154:5582–5589
    [Google Scholar]
50. Wolinsky S. M., Korber B. T., Neumann A. U., Daniels M., Kuntsman K. J., Whetsell A. J., Furtado M. R., Cao Y., Ho D. D., Safrit J. T. 1996; Adapt ive evolution of human immunodeficiency virus -type 1 during the natural course of infection. Science 272:537–542
    [Google Scholar]
51. Yamamoto H., Ringler D. J., Miller M. D., Yasutomi Y., Hasunum T., Letvin N. L. 1992; Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys. Journal of Immunology 149:728–734
    [Google Scholar]
52. Yasutomi Y., Koenig S., Woods R. M., Madsen J., Wassef N. M., Alving C. R., Klein H. J., Nolan T. E., Boots L. J., Kessler J. A., Emini E. A., Conley A. J., Letvin N. L. 1995; A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against cell-free simian immunodeficiency virus challenge. Journal of Virology 69:2279–2284
    [Google Scholar]
53. Zinkernagel R. M. 1995; Are HIV-specific CTL responses salutary or pathogenic?. Current Opinions in Immunology 7:462–470
    [Google Scholar]